Over 200 pharmacy stakeholder and patient advocacy groups sent a letter to Senators Chuck Grassley and Ron Wyden, chairman and ranking member of the Senate Finance Committee, urging them to include DIR fee reform in their drug pricing legislation. NASPA, along with NCPA, APhA, and many state pharmacy associations, signed on to the letter. The […]
National Pharmacy Organizations Write Azar Regarding Drug Importation
NASPA, along with the American Pharmacists Association (APhA) and the National Association of Chain Drug Stores (NACDS), wrote U.S. Department of Health and Human Services Secretary Azar this week regarding state prescription drug importation plans. All three organizations oppose the approval of a state drug importation program that meets a lower standard than that set […]
PTCB Awards Medication Safety Grants to State Associations
The Pharmacy Technician Certification Board (PTCB) has awarded grants to support projects that promote medication safety and advance the role of pharmacy technicians to four state pharmacy associations including the Iowa Pharmacy Association, North Dakota Pharmacists Association, and the Tennessee Pharmacists Association. “PTCB continually collaborates with state pharmacy associations to advance patient safety and care,” […]
Pharmacy Groups Applaud Bipartisan Effort for DIR Relief
National pharmacy organizations applauded the bipartisan Congressional focus on closing the DIR loophole in the recent Medicare rule. Last week, 105 members of the House of Representatives sent the Trump Administration a letter, and 28 senators sent a similar letter. NASPA, along with National Community Pharmacists Association, National Association of Chain Drug Stores, American Pharmacists […]
Over 100 Organizations Urge Congress to Oppose Importation of Non-FDA Approved Drugs
Over 100 health, patient advocacy, and law enforcement organizations, including NASPA and state pharmacy associations, signed on to a letter sent to President Trump and members of Congress asking them to safeguard patients and protect the secure U.S. prescription drug supply. The letter reminds the president and members of Congress that four previous FDA commissioners […]
Upsher-Smith Hosts NASPA/Pharmacists Mutual Leadership Conference
Upsher-Smith Laboratories recently hosted the NASPA/Pharmacists Mutual Leadership Conference at its Maple Grove headquarters on May 20-21, 2019. The two-day conference, which educates newly elected leaders and association executives on best practices in association governance and financial management, aims to strengthen the performance of state and national pharmacy associations across the United States, and to help raise public […]